Extralehdet Extralehdet
AstraZeneca Plc can absorb the financial impact of its recent deal with the US next year as demand for innovative medicines makes up for reduced prices in the world’s biggest pharma market, according to its chief financial officer.
Latest posts by Toimitus (see all)
